Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Harvard Business School
Dow
Colorcon
Chubb
Teva
Boehringer Ingelheim
US Army

Generated: April 21, 2018

DrugPatentWatch Database Preview

ARIMIDEX Drug Profile

« Back to Dashboard

When do Arimidex patents expire, and when can generic versions of Arimidex launch?

Arimidex is a drug marketed by Ani Pharms Inc and is included in one NDA.

The generic ingredient in ARIMIDEX is anastrozole. There are twenty-four drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the anastrozole profile page.
Drug patent expirations by year for ARIMIDEX
Pharmacology for ARIMIDEX
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Synonyms for ARIMIDEX
.alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
1,.alpha.,alpha.,alpha.',.alpha.'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
1,3-benzenediacetonitrile, a, a,a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
11A731
120511-73-1
2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
2-[3-(1-cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile)
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-[5-(1H-1,2,4-triazol-1-yl-methyl)-1,3-phenylene]-di(2-methyl propionitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2,2'-[5-(1H-1,2,4-triazole-1-yl-methyl)-1,3-phenylene]di(2-methyl propionitrile)
2,2"-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-Phenylene]bis(2-methyl-propiononitrile; Arimidex; ICI-D1033; ZD1033; a,a,a inverted exclamation marka,a inverted exclamation marka-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benz
2;2"-[5-(1H-1;2;4-Triazol-1-ylmethyl)-1
2Z07MYW1AZ
3-Phenylene]bis(2-methyl-propiononitrile
3B1-000676
a,a,a',a'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
A804526
AB0012887
AB00639929_11
AB00639929_13
AB00639929-06
AB00639929-08
AB00639929-09
AB00639929-10
AB1009242
AC-4234
AC1L1D49
ACT03222
AJ-07942
AK139140
AKOS015894980
alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
Alpha,alpha,alpha',alpha'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
AN-12153
anastrazole
anastrol
Anastrole
Anastrozol
anastrozole
Anastrozole (JAN/USAN/INN)
Anastrozole [USAN:INN:BAN]
Anastrozole [USAN:USP:INN:BAN]
Anastrozole(Arimidex)
AOB4816
API0001491
Arimidex (AstraZeneca)
Arimidex (TN)
Arimidex (Zeneca)
Arimidex, Anastrozole
Asiolex
Astra brand of anastrozole
AstraZeneca
AstraZeneca brand of anastrozole
AX8041216
B1382
BC202630
BCP9000301
BCPP000401
BDBM10015
BG0580
C-18412
C08159
C17H19N5
CA0164
CAS-120511-73-1
CC-24123
CCG-101109
CCRIS 9352
CHEBI:2704
CHEMBL1399
CPD000466301
CS-0716
D00960
D0W0BF
DB01217
DSSTox_CID_2607
DSSTox_GSID_22607
DSSTox_RID_76656
DTXSID9022607
EBD3898
FT-0602851
GTPL5137
HE058992
HE301227
HMS2052M11
HMS2089N10
HMS2235M06
HMS3369K05
HMS3394M11
HMS3654I18
HSDB 7462
HY-14274
I06-0021
ICI D1033
ICI-D 1033
ICI-D1033
KB-47397
KS-5052
LS-29563
MCULE-3029589501
MFCD00866298
MLS000759396
MLS001424217
MLS006011961
NC00359
NCGC00164619-01
NCGC00164619-02
NCGC00164619-04
NCGC00257356-01
NSC-719344
NSC-759855
NSC719344
NSC759855
Pharmakon1600-01502278
PubChem16625
QCR-114
RP17921
s1188
SAM001246525
SBB066057
SC-15687
SCHEMBL9726
SMR000466301
ST24038362
STL451008
tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile
Tox21_112238
Tox21_112238_1
Tox21_303568
UNII-2Z07MYW1AZ
W-5140
YBBLVLTVTVSKRW-UHFFFAOYSA-N
Z1522566626
ZD 1033
ZD-1033
ZD1033
Zeneca brand of anastrozole
Zeneca ZD 1033
ZINC941

US Patents and Regulatory Information for ARIMIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc ARIMIDEX anastrozole TABLET;ORAL 020541-001 Dec 27, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ARIMIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc ARIMIDEX anastrozole TABLET;ORAL 020541-001 Dec 27, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc ARIMIDEX anastrozole TABLET;ORAL 020541-001 Dec 27, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Baxter
Mallinckrodt
Healthtrust
Harvard Business School
Chinese Patent Office
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.